CRF type 1 receptors of the medial amygdala modulate inhibitory avoidance responses in the elevated T-maze

Hormones and Behavior

Volumn 65, Issue 3, 2014, Pages 195-202

  Vicentini, Jéssica E ^a   Céspedes, Isabel C ^a   Nascimento, Juliana O G ^a   Bittencourt, Jackson C ^b   Viana, Milena B ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anxiety; Corticotropin releasing factor; CRF; Elevated T maze; Fear; Medial amygdala; Panic

Indexed keywords

ANTALARMIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR; PYRIMIDINE DERIVATIVE; PYRROLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; ELEVATED T-MAZE TEST; LATENT PERIOD; LOCOMOTION; MALE; MEDIAL AMYGDALA; NEUROMODULATION; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; AMYGDALOID NUCLEUS; ANIMAL; ANIMAL BEHAVIOR; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; INHIBITION (PSYCHOLOGY); MAZE TEST; MOTOR ACTIVITY; PATHOLOGY; PHYSIOLOGY; SURGERY; WISTAR RAT;

ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; CORTICOMEDIAL NUCLEAR COMPLEX; CORTICOTROPIN-RELEASING HORMONE; INHIBITION (PSYCHOLOGY); MALE; MAZE LEARNING; MOTOR ACTIVITY; PYRIMIDINES; PYRROLES; RATS; RATS, WISTAR; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE;

EID: 84896875598     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2014.01.004     Document Type: Article

References (52)

1. Bangasser D.A. Sex differences in stress-related receptors: "micro" differences with "macro" implications for mood and anxiety disorders. Biol. Sex Differ. 2013, 4:1-13.
2. Bittencourt J.C., Sawchenko P.E. Do centrally administered neuropeptides access cognate receptors?: an analysis in the central corticotropin-releasing factor system. J. Neurosci. 2000, 20:1142-1156.
3. Blanchard D.C., Canteras N.S., Markham C.M., Pentkowski N.S., Blanchard R.J. Lesions of structures showing FOS expression to cat presentation: effects on responsivity to a Cat, Cat odor, and nonpredator threat. Neurosci. Biobehav. Rev. 2005, 29:1243-1253.
4. Brunton P.J., Donadio M.V., Russell J.A. Sex differences in prenatally programmed anxiety behaviour in rats: differential corticotropin-releasing hormone receptor mRNA expression in the amygdaloid complex. Stress 2011, 14:634-643.
5. Chen P., Hover C.V., Lindberg D., Li C. Central urocortin 3 and type 2 corticotropin-releasing factor receptor in the regulation of energy homeostasis: critical involvement of the ventromedial hypothalamus. Front. Endocrinol. (Lausanne) 2012, 3:180.
6. Coplan J.D., Pine D., Papp L., Martinez J., Cooper T., Rosenblum L.A., Gorman J.M. Uncoupling of the noradrenergic-hypothalamic-pituitary-adrenal axis in panic disorder patients. Neuropsychopharmacology 1995, 13:65-73.
7. Dayas C.V., Buller K.M., Day T.A. Neuroendocrine responses to an emotional stressor: evidence for involvement of the medial but not the central amygdala. Eur. J. Neurosci. 1999, 11:2312-2322.
8. Diniz L., dos Santos T.B., Britto L.R., Céspedes I.C., Garcia M.C., Spadari-Bratfisch R.C., Medalha C.C., de Castro G.M., Montesano F.T., Viana M.B. Effects of chronic treatment with corticosterone and imipramine on fos immunoreactivity and adult hippocampal neurogenesis. Behav. Brain Res. 2013, 238:170-177.
9. Fèkete E.M., Zorrilla E.P. Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs. Front. Neuroendocrinol. 2007, 28:1-27.
10. Fèkete E.M., Zhao Y., Li C., Sabino V., Vale W.W., Zorrilla E.P. Social defeat stress activates medial amygdala cells that express type 2 corticotropin-releasing factor receptor mRNA. Neuroscience 2009, 162:5-13.
11. Forestiero D., Manfrim C.M., Guimarães F.S., de Oliveira R.M. Anxiolytic-like effects induced by nitric oxide synthase inhibitors microinjected into the medial amygdala of rats. Psychopharmacology (Berl.) 2006, 184:166-172.
12. Forster G.L., Pringle R.B., Mouw N.J., Vuong S.M., Watt M.J., Burke A.R., Lowry C.A., Summers C.H., Renner K.J. Corticotropin-releasing factor in the dorsal raphe nucleus increases medial prefrontal cortical serotonin via type 2 receptors and median raphe nucleus activity. Eur. J. Neurosci. 2008, 28:299-310.
13. Graeff F.G., Zangrossi H. Animal models of anxiety. Biological Psychiatry 2002, 879-893. John Wiley & Sons, London. H. D'Haenen, J.A. Den Boer, P. Willner (Eds.).
14. Graeff F.G., Viana M.B., Tomaz C. The elevated T maze, a new experimental model of anxiety and memory: effect of diazepam. Braz. J. Med. Biol. Res. 1993, 26:67-70.
15. Graeff F.G., Garcia-Leal C., Del-Ben C.M., Guimarães F.S. Does the panic attack activate the hypothalamic-pituitary-adrenal axis?. An. Acad. Bras. Cienc. 2005, 77:477-491.
16. Heinrichs S.C., Pich E.M., Miczek K.A., Britton K.T., Koob G.F. Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action. Brain Res. 1992, 581:190-197.
17. Heinrichs S.C., Menzaghi F., Merlo Pich E., Britton K.T., Koob G.F. The role of CRF in behavioral aspects of stress. Ann. N.Y. Acad. Sci. 1995, 771:92-104.
18. Herdade K.C., Strauss C.V., Zangrossi H., Viana M.B. Effects of medial amygdala inactivation on a panic-related behavior. Behav. Brain Res. 2006, 172:316-323.
19. Herman J.P., Prewitt C.M., Cullinan W.E. Neuronal circuit regulation of the hypothalamo-pituitary-adrenocortical stress axis. Crit. Rev. Neurobiol. 1996, 10:371-394.
20. Hubbard D.T., Nakashima B.R., Lee I., Takahashi L.K. Activation of basolateral amygdala corticotropin-releasing factor 1 receptors modulates the consolidation of contextual fear. Neuroscience 2007, 150:818-828.
21. Institute of Laboratory Animal Resources Commission on Life Sciences.National Research Council 1996, National Academy Press, Washington, D.C.
22. Kemble E.D., Blanchard D.C., Blanchard R.J., Takushi R. Taming in wild rats following medial amygdaloid lesions. Physiol. Behav. 1984, 32:131-134.
23. Klein D.F. False suffocation alarms, spontaneous panics, and related conditions. An integrative hypothesis. Arch. Gen. Psychiatry 1993, 50:306-317.
24. Lee Y., Fitz S., Johnson P.L., Shekhar A. Repeated stimulation of CRF receptors in the BNST of rats selectively induces social but not panic-like anxiety. Neuropsychopharmacology 2008, 33:2586-2594.
25. Levine S. Developmental determinants of sensitivity and resistance to stress. Psychoneuroendocrinology 2005, 30:939-946.
26. Liebsch G., Landgraf R., Gerstberger R., Probst J.C., Wotjak C.T., Engelmann M., Holsboer F., Montkowski A. Chronic infusion of a CRH1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats. Regul. Pept. 1995, 59:229-239.
27. Lukkes J.L., Forster G.L., Renner K.J., Summers C.H. Corticotropin-releasing factor 1 and 2 receptors in the dorsal raphé differentially affect serotonin release in the nucleus accumbens. Eur. J. Pharmacol. 2008, 578:185-193.
28. Merchentaler L. Corticotropin releasing factor (CRF)-like immunoreactivity in the rat central nervous system. Extrahypothalamic distribution. Peptides 1984, 5:53-69.
29. Miguel T.T., Gomes K.S., Nunes-de-Souza R.L. Contrasting effects of nitric oxide and corticotropin-releasing factor within the dorsal periaqueductal gray on defensive behavior and nociception in mice. Braz. J. Med. Biol. Res. 2012, 45:299-307.
30. Muller M., Fendt M. Temporary inactivation of the medial and basolateral amygdala differentially affects TMT-induced fear behavior in rats. Behav. Brain Res. 2006, 167:57-62.
31. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 2008, Academic Press, Sidney. Compact Sixth edition.
32. Pentkowski N.S., Tovote P., Zavala A.R., Litvin Y., Blanchard D.C., Spiess J., Blanchard R.J. Cortagine infused into the medial prefrontal cortex attenuates predator-induced defensive behaviors and Fos protein production in selective nuclei of the amygdala in male CD1 mice. Horm. Behav. 2013, 64:519-526.
33. Pitts M.W., Todorovic C., Blank T., Takahashi L.K. The central nucleus of the amygdala and corticotropin-releasing factor: insights into contextual fear memory. J. Neurosci. 2009, 29:7379-7388.
34. Poltronieri S., Zangrossi H., Viana M.B. Antipanic-like effect of serotonin reuptake inhibitors in the elevated T-maze. Behav. Brain Res. 2003, 147:185-192.
35. Rainnie D.G., Bergeron R., Sajdyk T.J., Patil M., Gehlert D.R., Shekhar A. Corticotrophin releasing factor-induced synaptic plasticity in the amygdala translates stress into emotional disorders. J. Neurosci. 2004, 24:3471-3479.
36. Rassnick S., Hoffman G.E., Rabin B.S., Sved A.F. Injection of corticotropin-releasing hormone into the locus coeruleus or foot shock increases neuronal Fos expression. Neuroscience 1993, 85:259-268.
37. Risbrough V.B., Stein M.B. Role of corticotropin releasing factor in anxiety disorders: a translational research perspective. Horm. Behav. 2006, 50:550-561.
38. Roy-Byrne P.P., Uhde T.W., Post R.M., Gallucci W., Chrousos G.P., Gold P.W. The corticotropin-releasing hormone stimulation test in patients with panic disorder. Am. J. Psychiatry 1986, 143:896-899.
39. Sah P., Faber E.S., Lopez De Armentia M., Power J. The amygdala complex: anatomy and physiology. Physiol. Rev. 2003, 83:803-834.
40. Sajdyk T.J., Schober D.A., Gehlert D.R., Shekhar A. Role of corticotropin-releasing factor and urocortin within the basolateral amygdala of rats in anxiety and panic responses. Behav. Brain Res. 1999, 100:207-215.
41. Sena L.M., Bueno C., Pobbe R.L.H., Andrade T.C.G., Zangrossi H., Viana M.B. The dorsal raphe nucleus exerts opposed control on generalized anxiety and panic-related defensive responses in rats. Behav. Brain Res. 2003, 142:125-133.
42. Spiga F., Lightman S.L., Shekhar A., Lowry C.A. Injections of urocortin 1 into the basolateral amygdala induce anxiety-like behavior and c-Fos expression in brainstem serotonergic neurons. Neuroscience 2006, 138:1265-1276.
43. Swanson L.W., Sawchenko P.E., Rivier J., Vale W.W. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 1983, 36:165-186.
44. Swiergiel A.H., Takahashi L.K., Kalin N.H. Attenuation of stress-induced behavior by antagonism of corticotropin-releasing factor receptors in the central amygdala in the rat. Brain Res. 1993, 623:229-234.
45. Takahashi L.K. Role of CRF(1) and CRF(2) receptors in fear and anxiety. Neurosci. Biobehav. Rev. 2001, 25:627-636.
46. Teixeira R.C., Zangrossi H., Graeff F.G. Behavioral effects of acute and chronic imipramine in the elevated T-maze model of anxiety. Pharmacol. Biochem. Behav. 2000, 65:571-576.
47. Terleph T.A., Klein R.G., Roberson-Nay R., Mannuzza S., Moulton J.L., Woldehawariart G., Guardino M., Pine D.S. Stress responsivity and HPA axis activity in juveniles: results from a home-based CO2 inhalation study. Am. J. Psychiatry 2006, 163:738-740.
48. Uwano T., Nishijo H., Ono T., Tamura R. Neuronal responsiveness to various sensory stimuli, and associative learning in the rat amygdala. Neuroscience 1995, 68:339-361.
49. Van Duinen M.A., Schruers K.R., Maes M., Griez E.J. CO2 challenge induced HPA axis activation in panic. Int. Neuropsychopharmacol. 2007, 10:797-804.
50. Viana M.B., Tomaz C., Graeff F.G. The elevated T-maze: A new animal model of anxiety and memory. Pharmacol. Biochem. Behav. 1994, 49:549-554.
51. Wiersma A., Knollema S., Konsman J.P., Bohus B., Koolhaas J.M. Corticotropin-releasing hormone modulation of a conditioned stress response in the central amygdala of Roman high (RHA/Verh)-avoidance and low (RLA/Verh)-avoidance rats. Behav. Genet. 1997, 27:547-555.
52. 2 receptors. PLoS One 2013, 8:1-6.